Lipitor vs. Praluent
See how Lipitor and Praluent compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Lipitor is a daily statin pill available as a low-cost generic since 2011, while Praluent is an injectable PCSK9 inhibitor with no generic option.
Praluent is typically added to statin therapy when LDL remains too high, or used to lower cardiovascular risk after a heart attack or in established heart disease.
Lipitor carries a small risk of muscle and liver-related side effects, while Praluent's most common side effects are injection site reactions and flu-like symptoms.
Lipitor vs. Praluent Drug Summary
Lipitor
Lipitor (atorvastatin) is a statin that lowers LDL cholesterol and triglycerides by blocking an enzyme the liver uses to make cholesterol. It's taken as a once-daily tablet, with doses ranging from 10 mg to 80 mg. It's approved for adults and children with high cholesterol, including inherited forms, and to reduce heart attack and stroke risk in people with cardiovascular risk factors.
Praluent
Praluent (alirocumab) is a PCSK9 inhibitor, an injectable monoclonal antibody that lowers LDL cholesterol by helping the liver clear more of it from the blood. It's self-injected under the skin every 2 or 4 weeks, usually alongside a statin. It's approved for adults with high cholesterol, familial hypercholesterolemia, and for reducing cardiovascular events in people with existing heart disease.
Lipitor vs. Praluent Side Effects
Lipitor
Praluent
Lipitor vs. Praluent Dosage
Lipitor
Praluent
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 80 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 75 mg every 2 weeks | At the start |
| Maximum dose | 300 mg every 4 weeks | If needed |
| Dose changes | 2 increases | As tolerated |
Lipitor
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 80 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Praluent
| STAGE | DOSE | WHEN |
| Starting dose | 75 mg every 2 weeks | At the start |
| Maximum dose | 300 mg every 4 weeks | If needed |
| Dose changes | 2 increases | As tolerated |
Lipitor vs. Praluent Indications
Lipitor
Lipitor is FDA-approved to lower LDL cholesterol and triglycerides in adults and children 10 and older with dyslipidemia. It also reduces the risk of heart attack, stroke, and certain heart procedures in people with cardiovascular risk factors, including those with type 2 diabetes. It additionally treats both heterozygous and homozygous familial hypercholesterolemia.
Lowers LDL cholesterol and triglycerides in adults and children 10+
Reduces heart attack and stroke risk with cardiovascular risk factors
Reduces heart attack and stroke risk with type 2 diabetes
Treats heterozygous familial hypercholesterolemia in adolescents
Praluent
Praluent is FDA-approved to lower LDL cholesterol in adults with primary hyperlipidemia, usually added to a statin already at its highest tolerated dose. It also treats heterozygous familial hypercholesterolemia in adults and children 8 and older. In people with established heart disease, it reduces the risk of heart attack, stroke, and hospitalization for unstable angina.
Lowers LDL cholesterol as add-on to statin therapy
Treats heterozygous familial hypercholesterolemia in adults and kids 8+
Reduces heart attack and stroke risk in cardiovascular disease
Reduces hospitalization risk for unstable angina
Lipitor vs. Praluent Pros and Cons
Lipitor
Lipitor has decades of safety data and is available as an inexpensive generic tablet taken once daily. It carries a real, if small, risk of muscle and liver side effects that can require occasional monitoring.
Pros
Oral tablet, no injections needed
Available as a low-cost generic (atorvastatin) since 2011
Approved for homozygous familial hypercholesterolemia, unlike Praluent
Decades of long-term safety data since its 1996 approval
Cons
Small risk of muscle pain, myopathy, or rhabdomyolysis
Can raise liver enzymes; contraindicated in active liver disease
Interacts with several other medications through liver enzymes
May not lower LDL enough on its own for some high-risk patients
Praluent
Praluent offers a non-statin option for lowering LDL cholesterol, given by injection every two or four weeks instead of a daily pill. It has strong outcomes data in people with existing heart disease, but it comes with no generic alternative and a different side effect profile than statins.
Pros
Lowers LDL further when statins alone aren't enough
Only self-injected PCSK9 inhibitor with 2-week or monthly dosing
Reduces major cardiovascular events after acute coronary syndrome
Fewer drug-drug interactions since it isn't processed by liver enzymes
Cons
Requires injections instead of a daily pill
Injection site reactions are common
No generic or biosimilar version available in the US
Not approved for homozygous familial hypercholesterolemia or under age 8
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.